Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice-Reference-Cited by-同舟云学术

Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice

Published:2012-03 Issue:3 Volume:65 Page:285-296
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

De Sarro Giovambattista,Paola Eugenio Donato Di,Gratteri Santo,Gareri Pietro,Rispoli Vincenzo,Siniscalchi Antonio,Tripepi Giovanni,Gallelli Luca,Citraro Rita,Russo Emilio

Publisher

Elsevier BV

Subject

Pharmacology

Reference67 articles.

1. Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X);Bialer;Epilepsy Res,2010

2. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy;Perucca;Neurology,2009

3. The pharmacological treatment of epilepsy in adults;Perucca;Lancet Neurol,2011

4. The treatment of chronic epilepsy: a review of recent studies of clinical efficacy and side effects;Shorvon;Curr Opin Neurol,2007

5. Biochemistry and pharmacology of the rennin–angiotensin system;Johnston;Drugs,1990

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy;European Journal of Pharmacology;2024-01

2. Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP;Frontiers in Neurology;2023-08-23

3. Emerging Role of ACE-2 in Cerebrovascular and Neurological Disorders: Lessons Learnt from COVID-19;The Renin Angiotensin System in Cardiovascular Disease;2023

4. Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats;European Journal of Pharmacology;2022-08

5. Advancements in neuroactive peptides in seizures;Expert Review of Neurotherapeutics;2022-01-31